Global Assisted Reproductive Technology Market is anticipated to rise at a value CAGR of 7.2% over 2019-2028. According to a study published by Insure Insights on the Global Assisted Reproductive Technology Market. Assisted Reproductive Technology are those procedures done to treat infertility. These treatments are done for both men and women here, a woman’s egg taken out, and then the eggs are then mixed with sperm to make embryos and thus is fertilized. The government initiatives and increase in the R&D activities for Assisted Reproductive Technology are expanding the market growth.

Top Driver: The surge in infertility cases around the world have driven the market

The rise in the incidences of infertility around the globe and delaying pregnancy have positively impacted the market of the Global Assisted Reproductive Technology Market. Lifestyle habits like smoking and alcohol consumption have further increased the chances of infertility among couples. The unhealthy food habits like increased intake of caffeine, unhealthy food have triggered infertility thus have positively impacted the market. Advancement in assisted reproductive technology have to lead to higher success rates and minimized complications in pregnancy and have propelled the market

Fresh nondonor has made the highest segmental growth in the Global Assisted Reproductive Technology Market

Based on procedure the market is segmented as Fresh Donor, Fresh Nondonor, Frozen Donor, and Frozen Nondonor. Fresh non-donor has held the most lucrative growth as High success rates associated with fresh non -donors as compare with other procedures period. IVF with ICSI is widely done with fresh non-donor eggs or embryos.

In terms of the Applications, IVF segment has held the most remarkable growth in the market due to the rise in the cases of infertility among couples, and also due to other complications with couples, the Advancements in treatment procedures have further attributed to the growth. Based on the End User Fertility clinics, segment have held the most significant market growth, owing to the ability of trained physicians and better advance healthcare infrastructure.

The rise in infertility rate boosts the regional market of Europe  

The rise in the cases of infertility in the region and growing awareness among people for fertility treatment has significantly driven market growth. Moreover, the technological advancements and government initiatives for fertility treatment have further boosted the market of Europe. The growth in the aging population and delaying pregnancy among couples have positively impacted the market. The increase in healthcare expenditure and advanced healthcare infrastructure have mounted the demand for Assisted Reproductive Technology. The Rising awareness through campaigns about  Assisted Reproductive Technology has further driven the market

Technological advancements, Product launches, Mergers, and Acquisition, are the major strategies of the competitors

The Players of the Global Assisted Reproductive Technology Market is fragmented.  Technological advances, Product launches, Mergers, and Acquisition, are strategies used by the competitors   The key competitors of the Global Assisted Reproductive Technology Market California Cryobank, Bloom IVF Centre, Parallabs, Anecova, Origio, Microm Ltd., Merck KGaA, Cooper Surgical, Inc, Ferring Pharmaceuticals, and Hamilton Throne Ltd.

California Cryobank: California Cryobank, is one of the key competitors of the Global Assisted Reproductive Technology Market; for instance, In September 2019, California Cryobank, had announced the acquisition of Natera’s Evercord Cord Blood business. The acquisition was made by California Cryobank to strengthen its business.

Cooper Surgical, Inc:  Cooper Surgical, Inc is a popular competitor in the Global Assisted Reproductive Technology Market. In April 2018, Cooper Surgical had announced the acquisition of assets of The Life Global; they are a leading global provider of in-vitro fertilization (IVF) devices. The deal was done for USD 125 million. The acquisition was made by Cooper Surgical to strengthen its product portfolio by providing high-quality products and services, to help specialists improve patient outcomes and increase the chances of a healthy pregnancy.

 Scope of the Report

By Procedure

• Fresh Donor
• Fresh Nondonor
• Frozen Donor
• Frozen Nondonor

By Application

• IVF
• Artificial Insemination-Intrauterine Insemination (AI-IUI)
• Frozen Embryo Replacement
• Others

By End User

• Hospitals
• Fertility Clinics

By Region

• North America
• Europe
• Asia Pacific
• LAMEA

Key Reasons to Purchase this Report

1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.